Pembrolizumab Plus Radiation Fails to Improve Recurrence-Free Survival in Early-Stage High-Intermediate–Risk dMMR Endometrial Cancer
Ahead of the meeting, the trial was noted for restricting enrollment to patients with dMMR disease, in contrast…